Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Artery|January 1, 1980
Clinical experience with bezafibrateR Schubotz, J Schneider, L Hausmann, et al.Fortschritte Der Medizin|October 25, 1979
[Current aspects of rheumatoid arthritis]K M Goebel, E Hahn, L Hausmann, et al.Artery|January 1, 1980
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observationsH Kaffarnik, J Schneider, R Schubotz, et al.Zeitschrift Fur Gastroenterologie|May 23, 2013
[Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany]I Blumenstein, W Tacke, N Filmann, et al.Diseases of the Colon and Rectum|April 1, 1993
Comparison between endoscopic laser and different surgical treatments for palliation of advanced rectal cancerW Tacke, S Paech, W Kruis, et al.Atherosclerosis|January 1, 1978
Plasma lipids, triglyceride/fatty acid pattern, and plasma insulin in fasted healthy volunteers during continuous ingestion of ethanol. Influence of lipolysis inhibited by nicotinic acidH Kaffarnik, J Schneider, R Schubotz, et al.European Journal of Clinical Pharmacology|February 19, 1979
Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterolJ Schneider, R Müller, W Buberl, et al.Fortschritte Der Medizin|December 8, 1977
[Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias]H Kaffarnik, G Mühlfellner, O Mühlfellner, et al.Journal of Crohn'S & Colitis|May 18, 2011
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based studyI Blumenstein, E Herrmann, N Filmann, et al.Zeitschrift Fur Kardiologie|July 1, 1978
[Coronary artery reserve in patients with hyperlipoproteinemias (author's transl)]H Kaffarnik, B Braun, C Eltze, et al.Pageof 4